News Provided By
December 2, 2024, 12:32 GMT
Rockville, MD, United States, December 12, 2024 — On Demand Pharmaceuticals (ODP), a pioneering private company revolutionizing pharmaceutical production, is pleased to announce the launch of its first production sites to support ODP’s distributed vision. The successful qualification of ODP’s innovative equipment and capabilities support the envisioned cGMP operations enabling regional raw material production and repackaging (Rockville, Maryland) and agile point of care production of pharmaceuticals (Tupelo, Mississippi). This successful achievement marks a significant milestone in ODP’s development of its 503b compounding capabilities and point-of-care production approach. This significant milestone underscores ODP’s commitment to cGMP compliance, producing high-quality medications and enhancing the resilience of the domestic medicine supply chain.
The cGMP regulations set forth by the FDA establish rigorous standards for manufacturing, processing, and packaging of drug products to ensure their safety, efficacy, and quality. “Ensuring cGMP compliance is a critical component to our success, and this achievement is a testament to our dedication to excellence in essential medicine production,” said Matthew Pietras, CEO and CFO of On Demand Pharmaceuticals. “This accomplishment enables us to advance our mission of providing medications for everyone, everywhere, every time.”
The company remains committed to upholding the highest standards of quality and regulatory adherence as it continues to innovate in the field of pharmaceutical manufacturing and production.
About On Demand Pharmaceuticals
On Demand Pharmaceuticals™ is a new kind of pharmaceutical company transforming how medicines are produced and delivered by enabling on-demand production—at or near the point of care to provide a high-quality, safe, and reliable supply of medicines to every community.
For media inquiries, please contact:
On Demand Pharmaceuticals
301-701-6998
Note: This press release contains forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those expressed or implied herein.